Emerging technical/medical tools

HD vascular access 1

 

Pharmacologic treatments to improve vascular access outcome include use of aspirin and other antiplatelet drugs. Extended-release dipyridamole plus low-dose aspirin  prolongs primary unassisted graft patency of newly created hemodialysis AV grafts. However, the beneficial effects of anticoagualants and anti platelet drugs may be counteracted by an increased bleeding tendency and mortality risk.

There have been a number of different approches adopted to improve AV graft patency, ranging from newer nanotechnology-manufactured synthetic grafts, using  newer polymer materials and designs,  to tissue-enginered grafts. Several of them are now entering clinical trials, and preliminary data to date from completely autologous vascular graft grown in culture.

Advertisements

About azaleaazelia

A nice person... :)
This entry was posted in Tak Berkategori. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s